Nelotanserin Terminated Phase 2 Trials for Dementia With Lewy Body Disease / Visual Hallucinations / Parkinsons Disease With Dementia (PDD) / Rapid Eye Movement Sleep Behavior Disorder Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02871427Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder